KNTE

Kinnate Biopharma Inc. Common Stock

Delisted

KNTE was delisted on the 2nd of April, 2024.

79 hedge funds and large institutions have $249M invested in Kinnate Biopharma Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 23 increasing their positions, 26 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
79
Holders Change
-5
Holders Change %
-5.95%
% of All Funds
1.27%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.08%
New
10
Increased
23
Reduced
26
Closed
13
Calls
$1K
Puts
$1K
Net Calls
Net Calls Change
-$569K
Name Holding Trade Value Shares
Change
Shares
Change %
US Bancorp
76
US Bancorp
Minnesota
$689 -$11.9K -1,949 -95%
Dimensional Fund Advisors
77
Dimensional Fund Advisors
Texas
$234 -$3 -510 -1%
Federated Hermes
78
Federated Hermes
Pennsylvania
$24 -$1.85M -307,796 -100%
CS
79
Credit Suisse
Switzerland
$6 -$984 -164 -99%
DM
80
Deerfield Management
New York
-$2.99M -250,000 Closed
EC
81
EcoR1 Capital
California
-$2.09M -175,000 Closed
Millennium Management
82
Millennium Management
New York
-$943K -78,889 Closed
TI
83
Trexquant Investment
Connecticut
-$288K -24,117 Closed
Two Sigma Investments
84
Two Sigma Investments
New York
-$123K -10,258 Closed
BNP Paribas Financial Markets
85
BNP Paribas Financial Markets
France
-$111K -9,275 Closed
LC
86
Lindbrook Capital
California
-$13K -1,068 Closed
QCG
87
Quadrant Capital Group
Ohio
-$5K -428 Closed
EI
88
Ellevest Inc
New York
-$5K -385 Closed
PHK
89
Point72 Hong Kong
Hong Kong
-$3K -248 Closed
Carson Wealth (CWM LLC)
90
Carson Wealth (CWM LLC)
Nebraska
-$1K -80 Closed